Ceesay Abraham
CIK 1722140
Transactions on file
42
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-23 | 2026-10-21 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,210 | $64.4K | -11.1% | open → |
| 2026-10-08 | 2026-10-07 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 1,147 | $35.2K | -15.4% | open → |
| 2026-10-08 | 2026-10-06 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 3,375 | $108.1K | -19.0% | open → |
| 2026-09-24 | 2026-09-23 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 43 | $1.8K | -36.8% | open → |
| 2026-09-24 | 2026-09-23 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 215 | $8.6K | -34.9% | open → |
| 2026-09-24 | 2026-09-23 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 1,952 | $76.2K | -33.6% | open → |
| 2026-09-09 | 2026-09-08 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 1,069 | $49.2K | -43.6% | open → |
| 2026-09-09 | 2026-09-08 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 7,141 | $325.3K | -43.1% | open → |
| 2026-08-26 | 2026-08-25 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 18,921 | $938.0K | -47.7% | open → |
| 2026-08-12 | 2026-08-11 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 5,794 | $281.7K | -46.7% | open → |
| 2026-08-12 | 2026-08-11 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 19,500 | $936.8K | -46.0% | open → |
| 2026-08-12 | 2026-08-11 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 3,664 | $171.8K | -44.7% | open → |
| 2026-08-12 | 2026-08-10 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 8,370 | $391.3K | -44.5% | open → |
| 2026-08-12 | 2026-08-10 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 14,171 | $651.5K | -43.6% | open → |
| 2026-07-29 | 2026-07-27 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 7 | $299.14 | -39.3% | open → |
| 2026-07-29 | 2026-07-27 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,203 | $92.8K | -38.4% | open → |
| 2026-07-15 | 2026-07-14 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,729 | $110.7K | -36.1% | open → |
| 2026-07-15 | 2026-07-14 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 5,481 | $217.7K | -34.7% | open → |
| 2026-07-01 | 2026-06-29 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 876 | $35.3K | -35.7% | open → |
| 2026-07-01 | 2026-06-29 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 7,344 | $292.1K | -34.8% | open → |
| 2026-05-11 | 2026-05-08 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Grant | 1,438 | $255.4K | +94.4% | open → |
| 2025-06-04 | 2025-06-02 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Director | Grant | 946 | $127.7K | +155.8% | open → |
| 2025-06-13 | 2025-06-11 | PCRX Pacira BioSciences, Inc. | Director | Grant | 6,163 | $0.00 | — | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 515 | $16.0K | -16.5% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,421 | $72.7K | -13.7% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,147 | $61.9K | -10.1% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 600 | $18.6K | -16.5% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,792 | $83.9K | -13.7% | open → |
| 2025-12-18 | 2025-12-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,441 | $70.4K | -10.1% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,841 | $72.3K | +1.9% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,242 | $55.8K | +4.1% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 3,056 | $77.7K | +2.0% | open → |
| 2025-11-18 | 2025-11-17 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 2,777 | $69.2K | +4.0% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 755 | $19.8K | -0.9% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 4,328 | $111.4K | +0.7% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 1,186 | $31.0K | -0.8% | open → |
| 2025-10-16 | 2025-10-15 | RAPP Rapport Therapeutics, Inc. | Chief Executive Officer | Sale | 4,647 | $119.5K | +0.8% | open → |
| 2025-09-08 | 2025-09-04 | PCRX Pacira BioSciences, Inc. | Director | Sale | 2,354 | $64.0K | +33.9% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 700 | $18.9K | -4.1% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 34,885 | $917.5K | -1.4% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 1,400 | $37.6K | -3.5% | open → |
| 2025-09-19 | 2025-09-17 | RAPP Rapport Therapeutics, Inc. | OfficerDirector Chief Executive Officer | Sale | 39,435 | $1.04M | -1.4% | open → |
